Therefore, further Pearson analysis was conducted to investigate the correlation between GPR65 and common cancer immune checkpoint inhibitors, such as CD200R1, CD47, HAVCR2, TIGIT, CTLA4, LAG3, and PD1. This evidence concerns the gene GPR65 and cancer.